Quantitative Neuromuscular Monitoring Guidelines

This guide outlines the recommendations from the American Society of Anesthesiologists (ASA) and the European Society of Anaesthesiology and Intensive Care (ESAIC) regarding the use of quantitative neuromuscular monitoring to prevent postoperative residual neuromuscular block (PRNB). It emphasizes the importance of monitoring, especially when using reversal agents like sugammadex, as failure to do so can lead to significant risks of PRNB. The document presents data showing that the incidence of PRNB can be as high as 33% without proper monitoring. It details the benefits of achieving a train-of-four ratio (TOFR) greater than 0.90, which is associated with a 43% reduction in postoperative pulmonary complications. Additionally, the guide discusses the financial advantages of precise sugammadex dosing through quantitative monitoring, highlighting potential cost savings and reduced drug waste. The findings underscore the critical role of adherence to monitoring protocols in enhancing patient safety and optimizing resource allocation in clinical settings.